Literature DB >> 20175695

Identification of herpes simplex virus type 1 proteins encoded within the first 1.5 kb of the latency-associated transcript.

Gail Henderson1, Tareq Jaber, Dale Carpenter, Steven L Wechsler, Clinton Jones.   

Abstract

Expression of the first 1.5 kb of the latency-associated transcript (LAT) that is encoded by herpes simplex virus type 1 (HSV-1) is sufficient for wild-type (wt) levels of reactivation from latency in small animal models. Peptide-specific immunoglobulin G (IgG) was generated against open reading frames (ORFs) that are located within the first 1.5 kb of LAT coding sequences. Cells stably transfected with LAT or trigeminal ganglionic neurons of mice infected with a LAT expressing virus appeared to express the L2 or L8 ORF. Only L2 ORF expression was readily detected in trigeminal ganglionic neurons of latently infected mice.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20175695     DOI: 10.3109/13550280903296353

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  54 in total

Review 1.  Experimental investigation of herpes simplex virus latency.

Authors:  E K Wagner; D C Bloom
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Comprehensive quantification of herpes simplex virus latency at the single-cell level.

Authors:  N M Sawtell
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

3.  A protein encoded by the herpes simplex virus (HSV) type 1 2-kilobase latency-associated transcript is phosphorylated, localized to the nucleus, and overcomes the repression of expression from exogenous promoters when inserted into the quiescent HSV genome.

Authors:  S K Thomas; C E Lilley; D S Latchman; R S Coffin
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

4.  Persistence and reactivation of bovine herpesvirus 1 in the tonsils of latently infected calves.

Authors:  M T Winkler; A Doster; C Jones
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

5.  The herpes simplex virus latency-associated transcript is spliced during the latent phase of infection.

Authors:  E K Wagner; W M Flanagan; G Devi-Rao; Y F Zhang; J M Hill; K P Anderson; J G Stevens
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

6.  A herpes simplex virus type 1 latency-associated transcript mutant with increased virulence and reduced spontaneous reactivation.

Authors:  G C Perng; S M Slanina; A Yukht; B S Drolet; W Keleher; H Ghiasi; A B Nesburn; S L Wechsler
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

7.  Establishment and maintenance of HSV latent infection is mediated through correct splicing of the LAT primary transcript.

Authors:  Wen Kang; Ruma Mukerjee; Nigel W Fraser
Journal:  Virology       Date:  2003-07-20       Impact factor: 3.616

8.  Regulation of caspase 8- and caspase 9-induced apoptosis by the herpes simplex virus type 1 latency-associated transcript.

Authors:  Gail Henderson; Weiping Peng; Ling Jin; Guey-Chuen Perng; Anthony B Nesburn; Steven L Wechsler; Clinton Jones
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

9.  Methods for detecting the HSV-1 LAT anti-apoptosis activity in virus infected tissue culture cells.

Authors:  Ling Jin; Guey-Chuen Perng; David J Brick; Julia Naito; Anthony B Nesburn; Clinton Jones; Steven L Wechsler
Journal:  J Virol Methods       Date:  2004-06-01       Impact factor: 2.014

10.  A novel latency-active promoter is contained within the herpes simplex virus type 1 UL flanking repeats.

Authors:  W F Goins; L R Sternberg; K D Croen; P R Krause; R L Hendricks; D J Fink; S E Straus; M Levine; J C Glorioso
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

View more
  17 in total

1.  The herpes simplex virus type 1 latency associated transcript locus is required for the maintenance of reactivation competent latent infections.

Authors:  Richard L Thompson; Nancy M Sawtell
Journal:  J Neurovirol       Date:  2011-12-30       Impact factor: 2.643

Review 2.  Ocular herpes simplex virus: how are latency, reactivation, recurrent disease and therapy interrelated?

Authors:  Lena J Al-Dujaili; Patrick P Clerkin; Christian Clement; Harris E McFerrin; Partha S Bhattacharjee; Emily D Varnell; Herbert E Kaufman; James M Hill
Journal:  Future Microbiol       Date:  2011-08       Impact factor: 3.165

Review 3.  Control of HSV-1 latency in human trigeminal ganglia--current overview.

Authors:  Kathrin Held; Tobias Derfuss
Journal:  J Neurovirol       Date:  2011-12-03       Impact factor: 2.643

4.  The herpes simplex virus 1 latency-associated transcript promotes functional exhaustion of virus-specific CD8+ T cells in latently infected trigeminal ganglia: a novel immune evasion mechanism.

Authors:  Aziz A Chentoufi; Elizabeth Kritzer; Michael V Tran; Gargi Dasgupta; Chang Hyun Lim; David C Yu; Rasha E Afifi; Xianzhi Jiang; Dale Carpenter; Nelson Osorio; Chinhui Hsiang; Anthony B Nesburn; Steven L Wechsler; Lbachir BenMohamed
Journal:  J Virol       Date:  2011-06-29       Impact factor: 5.103

5.  Varicella zoster virus latency.

Authors:  Emily Eshleman; Aamir Shahzad; Randall J Cohrs
Journal:  Future Virol       Date:  2011-03       Impact factor: 1.831

6.  Towards an understanding of the herpes simplex virus type 1 latency-reactivation cycle.

Authors:  Guey-Chuen Perng; Clinton Jones
Journal:  Interdiscip Perspect Infect Dis       Date:  2010-02-15

Review 7.  A cultured affair: HSV latency and reactivation in neurons.

Authors:  Angus C Wilson; Ian Mohr
Journal:  Trends Microbiol       Date:  2012-09-07       Impact factor: 17.079

8.  The half-life of the HSV-1 1.5-kb LAT intron is similar to the half-life of the 2.0-kb LAT intron.

Authors:  Kerry K Brinkman; Prakhar Mishra; Nigel W Fraser
Journal:  J Neurovirol       Date:  2013-01-19       Impact factor: 2.643

9.  Herpes simplex virus 1 tropism for human sensory ganglion neurons in the severe combined immunodeficiency mouse model of neuropathogenesis.

Authors:  Leigh Zerboni; Xibing Che; Mike Reichelt; Yanli Qiao; Haidong Gu; Ann Arvin
Journal:  J Virol       Date:  2012-12-26       Impact factor: 5.103

Review 10.  Infectious agents and neurodegeneration.

Authors:  Giovanna De Chiara; Maria Elena Marcocci; Rossella Sgarbanti; Livia Civitelli; Cristian Ripoli; Roberto Piacentini; Enrico Garaci; Claudio Grassi; Anna Teresa Palamara
Journal:  Mol Neurobiol       Date:  2012-08-17       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.